Evaluation of serum thyroid-stimulating hormone as indicator for fine-needle aspiration in patients with thyroid nodules

Ji Soo Choi, Chung Mo Nam, Eun Kyung Kim, Hee Jung Moon, Kyung Hwa Han, Jin Young Kwak

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background Recently, it has been reported that the risk of thyroid malignancy increases with increasing concentrations of serum thyroid-stimulating hormone (TSH). The purpose of this study was to determine whether or not serum TSH can be a predictor for thyroid malignancy when considering the relevant ultrasound features and clinical risk factors. Methods This retrospective study included 1200 euthyroid patients with 1269 thyroid nodules who underwent ultrasound-guided fine-needle aspiration (FNA) biopsy between January and June 2009. Serum TSH, ultrasound feature, and clinical parameters were compared according to final diagnosis. Subgroup analyses were performed according to nodule size. Results Serum TSH did not show a positive association with malignancy for all nodules and the micronodule subgroup in multivariate analysis, although they showed significant association with thyroid malignancy for the macronodule subgroup. For all nodules and the 2 subgroups, suspicious ultrasound features and younger age were significantly associated with malignancy in univariate and multivariate analyses. Conclusion Our study suggests that TSH alone is not as useful as ultrasound features in deciding whether or not to perform FNA in patients with micronodules.

Original languageEnglish
Pages (from-to)498-504
Number of pages7
JournalHead and Neck
Volume37
Issue number4
DOIs
Publication statusPublished - 2015 Apr 1

Fingerprint

Thyroid Nodule
Thyrotropin
Fine Needle Biopsy
Serum
Thyroid Gland
Neoplasms
Multivariate Analysis
Retrospective Studies

All Science Journal Classification (ASJC) codes

  • Otorhinolaryngology

Cite this

@article{7e48ee698e7d43629c2d5b93366a4405,
title = "Evaluation of serum thyroid-stimulating hormone as indicator for fine-needle aspiration in patients with thyroid nodules",
abstract = "Background Recently, it has been reported that the risk of thyroid malignancy increases with increasing concentrations of serum thyroid-stimulating hormone (TSH). The purpose of this study was to determine whether or not serum TSH can be a predictor for thyroid malignancy when considering the relevant ultrasound features and clinical risk factors. Methods This retrospective study included 1200 euthyroid patients with 1269 thyroid nodules who underwent ultrasound-guided fine-needle aspiration (FNA) biopsy between January and June 2009. Serum TSH, ultrasound feature, and clinical parameters were compared according to final diagnosis. Subgroup analyses were performed according to nodule size. Results Serum TSH did not show a positive association with malignancy for all nodules and the micronodule subgroup in multivariate analysis, although they showed significant association with thyroid malignancy for the macronodule subgroup. For all nodules and the 2 subgroups, suspicious ultrasound features and younger age were significantly associated with malignancy in univariate and multivariate analyses. Conclusion Our study suggests that TSH alone is not as useful as ultrasound features in deciding whether or not to perform FNA in patients with micronodules.",
author = "Choi, {Ji Soo} and Nam, {Chung Mo} and Kim, {Eun Kyung} and Moon, {Hee Jung} and Han, {Kyung Hwa} and Kwak, {Jin Young}",
year = "2015",
month = "4",
day = "1",
doi = "10.1002/hed.23616",
language = "English",
volume = "37",
pages = "498--504",
journal = "Head and Neck",
issn = "1043-3074",
publisher = "John Wiley and Sons Inc.",
number = "4",

}

Evaluation of serum thyroid-stimulating hormone as indicator for fine-needle aspiration in patients with thyroid nodules. / Choi, Ji Soo; Nam, Chung Mo; Kim, Eun Kyung; Moon, Hee Jung; Han, Kyung Hwa; Kwak, Jin Young.

In: Head and Neck, Vol. 37, No. 4, 01.04.2015, p. 498-504.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Evaluation of serum thyroid-stimulating hormone as indicator for fine-needle aspiration in patients with thyroid nodules

AU - Choi, Ji Soo

AU - Nam, Chung Mo

AU - Kim, Eun Kyung

AU - Moon, Hee Jung

AU - Han, Kyung Hwa

AU - Kwak, Jin Young

PY - 2015/4/1

Y1 - 2015/4/1

N2 - Background Recently, it has been reported that the risk of thyroid malignancy increases with increasing concentrations of serum thyroid-stimulating hormone (TSH). The purpose of this study was to determine whether or not serum TSH can be a predictor for thyroid malignancy when considering the relevant ultrasound features and clinical risk factors. Methods This retrospective study included 1200 euthyroid patients with 1269 thyroid nodules who underwent ultrasound-guided fine-needle aspiration (FNA) biopsy between January and June 2009. Serum TSH, ultrasound feature, and clinical parameters were compared according to final diagnosis. Subgroup analyses were performed according to nodule size. Results Serum TSH did not show a positive association with malignancy for all nodules and the micronodule subgroup in multivariate analysis, although they showed significant association with thyroid malignancy for the macronodule subgroup. For all nodules and the 2 subgroups, suspicious ultrasound features and younger age were significantly associated with malignancy in univariate and multivariate analyses. Conclusion Our study suggests that TSH alone is not as useful as ultrasound features in deciding whether or not to perform FNA in patients with micronodules.

AB - Background Recently, it has been reported that the risk of thyroid malignancy increases with increasing concentrations of serum thyroid-stimulating hormone (TSH). The purpose of this study was to determine whether or not serum TSH can be a predictor for thyroid malignancy when considering the relevant ultrasound features and clinical risk factors. Methods This retrospective study included 1200 euthyroid patients with 1269 thyroid nodules who underwent ultrasound-guided fine-needle aspiration (FNA) biopsy between January and June 2009. Serum TSH, ultrasound feature, and clinical parameters were compared according to final diagnosis. Subgroup analyses were performed according to nodule size. Results Serum TSH did not show a positive association with malignancy for all nodules and the micronodule subgroup in multivariate analysis, although they showed significant association with thyroid malignancy for the macronodule subgroup. For all nodules and the 2 subgroups, suspicious ultrasound features and younger age were significantly associated with malignancy in univariate and multivariate analyses. Conclusion Our study suggests that TSH alone is not as useful as ultrasound features in deciding whether or not to perform FNA in patients with micronodules.

UR - http://www.scopus.com/inward/record.url?scp=84925631189&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925631189&partnerID=8YFLogxK

U2 - 10.1002/hed.23616

DO - 10.1002/hed.23616

M3 - Article

C2 - 24435826

AN - SCOPUS:84925631189

VL - 37

SP - 498

EP - 504

JO - Head and Neck

JF - Head and Neck

SN - 1043-3074

IS - 4

ER -